Navigating the implementation gap for Trastuzumab's journey from health insurance to patient access: a preliminary study in a hospital in China
Abstract Background Trastuzumab, a monoclonal antibody for breast cancer, faces global accessibility challenges, primarily due to high costs. This study examines how changes in medical insurance policies and price adjustments influence Trastuzumab utilization in China, focusing on implementation cha...
Saved in:
| Main Authors: | Xingxia Yang, Yufei Jia, Jianhong Xu, Qin Zhou, Qian Long, Yi Yang, Yunguo Liu, Juanying Zhu, Xiaochen Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-11-01
|
| Series: | Global Health Research and Policy |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s41256-024-00384-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Trastuzumab and cardiotoxicity
by: Petra Sertić, et al.
Published: (2024-01-01) -
Social medical insurance system and self-rated health: medical service utilization as the mechanism of action
by: Jian Zhou, et al.
Published: (2025-06-01) -
Impact of the Basic Mandatory Health Insurance “AMO-Tadamon” on Continuity of Care Among Breast Cancer Patients Treated at the Oncology Center of the CHU Mohammed VI in Tangier: A Mixed Longitudinal Cohort Study
by: Bouzini G, et al.
Published: (2025-04-01) -
Disitamab vedotin in preclinical models of HER2-positive breast and gastric cancers resistant to trastuzumab emtansine and trastuzumab deruxtecan
by: Negar Pourjamal, et al.
Published: (2025-03-01) -
Development and Validation of the ELISA Method for Anti-trastuzumab Antibodies Determination in Human Serum
by: O. A. Eliseeva, et al.
Published: (2022-12-01)